glp 1 covered by cigna prior authorization for Ozempic, Wegovy, Mounjaro & Zepbound Cigna will stop covering GLP-1
Description
GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) and liraglutide (Saxenda), as well as dual GIP/GLP-1 receptor agonists like tirzepatide (Zepbound, Mounjaro), are not automatically disqualifying medications
When treating such high-risk populations with incretin-based pharmacotherapy for weight loss, preserving muscle mass is crucial for preventing frailty, obesity-related comorbidities, maintaining metabolic health and improving physical function
Thats stuff like deductibles, copays, and coinsurance
UHC typically schedules peer-to-peer reviews within 5 to 7 business days of the request
The dose should not exceed 3.0 mg daily, and liraglutide can be administered at any time of day, with or without meals
Just be patient and stick with it, as consistency is key to achieving the best results over time
